Scancell Holdings is advancing its Nasdaq listing following a merger with US biotech Neuphoria Therapeutics, with shareholders voting on October 20. The deal includes $75 million in financing from private placements, UK equity offerings, and debt facilities, including a $25 million loan from BlackRock. Concurrently, Scancell received FDA and MHRA approval to start a phase III trial of its cancer vaccine iSCIB1+ for advanced melanoma, enrolling 550 patients across multiple countries. The company reported a £17.4 million operating loss for the year to April 2026 but expects the merger and funding to secure its financial needs for the next year. Early data from another trial, ModiFY, showed promising responses in head and neck cancer patients, with more results expected later in 2026.
Scancell's Nasdaq listing and phase III melanoma trial news provide context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 09, 2026 14:41 WIB: out of 128 priced US health stocks, 62 rose and 62 fell. Notable movers include Revolution Medicines Inc. (RVMD) at USD 189.00 with a -5.91% change, Ginkgo Bioworks Holdings Inc. (DNA) at USD 11.95 with a +5.38% change, and Twist Bioscience Corp (TWST) at USD 158.39 with a +4.17% change.
ZenaTech introduced Stacklens™, AI-powered smart safety glasses designed for field technicians and industrial workers, integrating hands-free AI assistance, real-time video support, and thermal imaging. The glasses aim to improve efficiency by allowi...
Last week saw two biotech companies successfully price their IPOs, alongside a billion-dollar data center developer, an emerging markets fintech, and a dental treatment company. Despite market caution limiting some IPO activity, biotechs remain activ...
The XRP Ledger patched a critical vulnerability in its payment engine that could have allowed attackers to create and spend XRP beyond the network's 100 billion token supply. The flaw, present in versions 3.4.0 and earlier, was fixed in version 3.4.1...
A decade-old bug in the XRP Ledger's payment system could have allowed attackers to create and spend new XRP tokens without funding them, violating the fixed supply of 100 billion XRP. The vulnerability involved a counting error in the ledger's built...
Coinbase's spot Bitcoin order book revealed a significant sell order of 61.63 BTC valued at about $5.1 million, placed slightly above the market midpoint price of $82,523. Nearby sell orders total approximately $23.4 million, while buy orders are clo...
